Projects per year
CONTESSA: A Multicenter, Phase 2 Study of Tesetaxel plus Three Different PD-(L)1 Inhibitors in Patients with Triple-Negative, Locally Advanced or Metastatic Breast Cancer and Tesetaxel Monotherapy in Elderly Patients with HER2 Negative, Locally Advanced or Metastatic Breast Cancer
Sabanathan, D., Park, J., Gilchrist, J., Rai, M. & Chapman, N.
1/05/20 → 31/12/21
Speckle-tracking Global Longitudinal Strain (GLS) for Early Detection of Cardiotoxicity from Anticancer Therapy